Hepatitis C virus (HCV) infection: a systemic disease

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis C virus (HCV) is a significant global health concern, affecting approximately 180 million people worldwide.
• HCV is both hepatotropic and lymphotropic, leading to chronic hepatitis, cirrhosis, hepatocellular carcinoma, and extrahepatic diseases like lymphoma.
• The association of HCV with hepatic and extrahepatic malignancies classifies it as a human cancer virus, underscoring the need to understand its pathogenesis.

Purpose of the Study:

• To review the principal aspects of HCV-induced systemic disease.
• To focus on the extrahepatic manifestations of Hepatitis C virus infection.
• To discuss the challenges in managing HCV-related sequelae, particularly extrahepatic manifestations.

Main Methods:

• Literature review of Hepatitis C virus (HCV) infection.
• Analysis of HCV's role in hepatic and extrahepatic diseases.
• Examination of current treatment strategies and therapeutic management.

Main Results:

• HCV infection is linked to severe hepatic conditions like cirrhosis and cancer.
• Extrahepatic manifestations, including mixed cryoglobulinemia and lymphoma, are significant sequelae of HCV infection.
• The pathogenesis of HCV-related hepatic and extrahepatic diseases remains incompletely understood.

Conclusions:

• HCV infection presents a complex challenge due to its diverse systemic and extrahepatic effects.
• Optimizing the clinical and therapeutic management of HCV patients requires a thorough understanding of its pathogenesis.
• Tailored, case-by-case therapeutic approaches are often necessary, especially for extrahepatic manifestations.